ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "High-Precision Cell Therapy: Orca Bio’s Nate Fernhoff"
Episode Synopsis
Today, we speak with Nate Fernhoff, Co-Founder and CEO of Orca Bio, a biotechnology company developing high-precision cell therapies to treat patients with blood cancers and immune diseases. By applying single-cell technology at scale, Orca Bio aims to deliver transplants that rebuild a patient’s blood and immune system while lowering the risk of serious complications.
Nate co-founded the company after his research at Stanford, where he helped translate decades of immunology into a platform ready for clinical use. Under his leadership, Orca Bio has advanced its lead program, Orca-T, which recently produced positive Phase 3 results, marking a critical milestone on the path to FDA review.
I am RJ Lumba, the host of The Healthcare Technology Report podcast. I am the Managing Partner of GrowthCap and Executive Chairman of Market Insight Media. We hope you enjoy the show. If you like the episode click to follow.
Nate co-founded the company after his research at Stanford, where he helped translate decades of immunology into a platform ready for clinical use. Under his leadership, Orca Bio has advanced its lead program, Orca-T, which recently produced positive Phase 3 results, marking a critical milestone on the path to FDA review.
I am RJ Lumba, the host of The Healthcare Technology Report podcast. I am the Managing Partner of GrowthCap and Executive Chairman of Market Insight Media. We hope you enjoy the show. If you like the episode click to follow.
More episodes of the podcast The Healthcare Technology Report with RJ Lumba
MedTech Leader: PAVmed’s Lishan Aklog
29/10/2025
In God we trust